Premier, Inc. (NASDAQ:PINC) Stock Holdings Lifted by BNP Paribas Financial Markets

BNP Paribas Financial Markets increased its holdings in shares of Premier, Inc. (NASDAQ:PINC - Free Report) by 162.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,863 shares of the company's stock after buying an additional 46,302 shares during the period. BNP Paribas Financial Markets owned about 0.08% of Premier worth $1,587,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in PINC. Barclays PLC increased its stake in shares of Premier by 32.2% in the 3rd quarter. Barclays PLC now owns 154,128 shares of the company's stock worth $3,081,000 after acquiring an additional 37,551 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in shares of Premier by 109.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 468,524 shares of the company's stock worth $9,933,000 after acquiring an additional 245,239 shares during the last quarter. Brooklyn Investment Group increased its stake in shares of Premier by 61,750.0% in the 4th quarter. Brooklyn Investment Group now owns 1,237 shares of the company's stock worth $26,000 after acquiring an additional 1,235 shares during the last quarter. Kera Capital Partners Inc. acquired a new stake in shares of Premier in the 4th quarter worth $248,000. Finally, Aaron Wealth Advisors LLC acquired a new stake in shares of Premier in the 4th quarter worth $220,000. Hedge funds and other institutional investors own 74.41% of the company's stock.

Analysts Set New Price Targets

PINC has been the subject of a number of recent research reports. Piper Sandler raised their target price on Premier from $19.00 to $24.00 and gave the stock a "neutral" rating in a research note on Wednesday. Canaccord Genuity Group raised their target price on Premier from $19.00 to $22.00 and gave the stock a "hold" rating in a research note on Thursday, May 8th. Finally, Robert W. Baird raised their price objective on Premier from $19.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, May 15th. Seven analysts have rated the stock with a hold rating, According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $22.20.

Insider Activity

In other news, General Counsel David L. Klatsky sold 10,982 shares of Premier stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $22.74, for a total value of $249,730.68. Following the completion of the transaction, the general counsel now owns 76,093 shares in the company, valued at approximately $1,730,354.82. This trade represents a 12.61% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last quarter, insiders sold 22,119 shares of company stock worth $464,974. 0.96% of the stock is currently owned by company insiders.

Premier Stock Down 0.6%

PINC stock traded down $0.14 during midday trading on Friday, hitting $23.06. The company's stock had a trading volume of 1,190,505 shares, compared to its average volume of 1,246,078. The firm has a 50-day simple moving average of $20.48 and a 200-day simple moving average of $20.71. The firm has a market capitalization of $1.90 billion, a P/E ratio of -230.58 and a beta of 0.54. Premier, Inc. has a 52-week low of $17.23 and a 52-week high of $23.56.

Premier Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, June 15th. Stockholders of record on Sunday, June 1st will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 3.64%. The ex-dividend date is Friday, May 30th. Premier's payout ratio is presently 147.37%.

Premier Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.